Non-Exclusive License Agreement. This Non-Exclusive License Agreement (this “Agreement”) is by and between Icahn School of Medicine at Mount Sinai, a New York not-for-profit education corporation, with a principal place of business at Oxx Xxxxxxx X. Xxxx Place, New York, NY 10029 (“Mount Sinai”) and Heart Test Laboratories, Inc. d/b/a HeartSciences a Texas corporation, with a principal place of business at 500 Xxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxx, XX 00000 (referred to herein as (“Licensee”). This Agreement shall become effective upon the Closing (the “Effective Date”), which shall be deemed the Closing Date. Mount Sinai and Licensee are each referred to herein as a “Party” and collectively as the “Parties.” Terms not defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement between the Parties, executed contemporaneously herewith (the “SPA”) and annexed hereto as Exhibit A.
Non-Exclusive License Agreement. This Non-Exclusive License Agreement and the attached Appendix A (collectively, the “Agreement”) is made and is effective this day of , 20 (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“The Regents” or “Licensor”), a California corporation having its corporate offices located at 0000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000-0000, acting through The Office of Intellectual Property and Industry Sponsored Research of the University of California, Los Angeles, located at 00000 Xxxxxxx Xxxxxx, Xxxxx 000, Xxx Xxxxxxx, XX 00000-0000, and the undersigned:
Non-Exclusive License Agreement. This Non-Exclusive License Agreement (the "Agreement") is dated this --------- ___ day of March, 2000 and is entered into by and between Xxxxxx Laboratories, an Illinois corporation having a principal place of business at 000 Xxxxxx Xxxx Road, Xxxxxx Park, Illinois, 60064-3500 ("Abbott"), and Anesta Corp., a Delaware ------ corporation having a principal place of business at 0000 Xxxxx Xxxx Way, Salt Lake City, Utah 84116 ("Anesta"). ------ BACKGROUND ----------
Non-Exclusive License Agreement. Within [***] ([***]) Business Days of the Escrow Agent’s receipt of an Option Notice, Omega and Acuitas will enter into a Non-Exclusive License using the form attached hereto as Exhibit 5.2(b) for the Licensed Products directed to the Reserved Target specified in the relevant Option Notice.
Non-Exclusive License Agreement. This Agreement is entered into as of the 20th day of October, 1999 (“Effective Date”) by and between the Xxxx Xxxxxxxxxx Cancer Research Center, a Washington non-profit corporation (“FHCRC”) and Xcyte Therapies, Inc (“LICENSEE”), a Delaware corporation having a place of business at 0000 Xxxxxxx Xxx X., Xxxxx 000, Xxxxxxx, Xxxxxxxxxx 00000. All references to LICENSEE shall include its AFFILIATES.
Non-Exclusive License Agreement. [ ] Other:
Non-Exclusive License Agreement. Within [**] of the Escrow Agent’s receipt of an Option Notice, Verve and Acuitas will enter into a Non-Exclusive License Agreement using the form specified in Appendix 1.48 for the Licensed Products specified in the relevant Option Notice.
Non-Exclusive License Agreement. This Non-exclusive License Agreement (the “Agreement”), effective as of November 30, 2001 (the “Effective Date”), is entered into by and between XOMA Ireland Limited (“XOMA”), an Irish company having offices located at Xxxxxxx Xxxxxxx Xxxxx, Xxxxxxx, Xxxxxx Xxxxx, Xxxxxxx, and Viventia Biotech Inc. (“VIVENTIA”), a Canadian corporation having offices located at 10 Four Seasons Place, Suite 510, Toronto, Ontario, Canada M9B 6H7.
Non-Exclusive License Agreement. Within fifteen (15) business days of the Escrow Agent’s receipt of an Option Notice, GreenLight and Acuitas will enter into a Non-Exclusive License Agreement using the form specified in Appendix 1.64 for the Licensed Products specified in the relevant Option Notice.
Non-Exclusive License Agreement. This Amendment No. 1 (the “Amendment”) is made as of December 8, 2021 (the “Amendment Effective Date”) by and between Imara Inc., a Delaware corporation having an address at 000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx, Xxxxxx, XX 00000 (“Licensee”) and the University of Pittsburgh – Of the Commonwealth System of Higher Education, a non-profit corporation, organized and existing under the laws of the Commonwealth of Pennsylvania, having an office at 1st Floor Xxxxxxx Steel Conference Center, 000 Xxxxxxxxx Xxxxxx, Xxxxxxxxxx Xxxxxxxxxxxx 00000 (“University”). Licensee and University may be referred to herein individually as a “Party” or collectively as the “Parties.”
